evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract
3306,GENE_BACKGROUND,,"PIK3CD, also known as p110-ẟ, is a catalytic subunit of PI3K that is important in creating phosphoinositol 3,4,5-trisphosphate (PIP3), which acts as a secondary messenger in key cellular signaling pathways such as AKT-mTOR. PIK3CD primarily functions in immune cells through AKT signaling. It is required for T-cell receptor activation (PMID: 12130661), and it is also necessary for a full antibody response in B-cells (PMID: 12235209). Germline mutations in PIK3CD likely causes both immunodeficiency and lymphoproliferative disease as a result of hyperactivation of AKT-mTOR signaling, which forces the differentiation of naive CD8+ T-cells into short-lived effector cells and reduces long-term memory T- and B-cells (PMID: 24165795). Idelalisib, a specific inhibitor of PIK3CD, has been used with Rituximab (a CD20 antibody) in the treatment of chronic lymphocytic leukemia (CLL) and has been associated with significant increase in progression-free survival (PMID: 24450857).",,2017-10-19,,5293,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",True,ENST00000377346,NM_005026.3,APDS,PI3K,p110D,IMD14,P110DELTA,False,24165795,Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.,Nature immunology,2018-01-01T20:14:00,15,True,88-97,Lucas CL et al,doi: 10.1038/ni.2771,,0001-01-01,,12235209,A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation.,The Journal of experimental medicine,2018-09-16T20:02:00,196,6,753-63,Clayton E et al,,,0001-09-16,,12130661,Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.,"Science (New York, N.Y.)",2018-08-09T20:02:00,297,5583,1031-4,Okkenhaug K et al,,,0001-08-09,,24450857,Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.,The New England journal of medicine,2018-03-13T20:14:00,370,11,997-1007,Furman RR et al,doi: 10.1056/NEJMoa1315226,,2018-03-13T10:07:00,
3305,GENE_SUMMARY,,"PIK3CD encodes a kinase involved in immune cell regulation. Inactivating mutations of PIK3CD are found in uterine, endometrial and colorectal cancers, among others.",,2017-04-26,,5293,PIK3CD,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",True,ENST00000377346,NM_005026.3,APDS,PI3K,p110D,IMD14,P110DELTA,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
